Clinical trials
Completed Amyloidosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| Advice Pharma Group srl | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Departemental Vendee | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| French Cardiology Society | 1 |
| Henry Ford Health System | 1 |
| Massachusetts General Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 18 |
| Multiple Myeloma | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Alzheimer Disease | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Anosmia | 1 |
| Aortic Valve Stenosis | 1 |
| Cardiomyopathies | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.